Save your place

Sign in to WhoBought

Please try again later.

Aquestive Therapeutics, Inc. (AQST) institutional ownership

Latest close $3.76 Jul 28, 2026
Market cap$565M 52-week range SectorHealthcare
Funds holding · Q1 2026
192
reported AQST position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
101 buyers · 91 sellers

Aquestive Therapeutics, Inc. (AQST) price and institutional activity

Dates

Q1 2026

$0 bought by 101 investors
Balyasny Asset Management L.P.Bank of America Corp +99 more
$0 sold by 91 investors
Ecor1 Capital, LLCMillennium Management LLC +89 more
Bought Sold Totals per quarter; hover a bar for the names.

Aquestive Therapeutics, Inc. (AQST) institutional activity · 192

Investor Type Est. change Change Δ Own Date
Ecor1 Capital, LLC · Exited
Change −2.6M Δ Own −100.0% Date Q1 2026
Ecor1 Capital, LLC Exited· Q1 2026 −2.6M −100.0% Q1 2026
Balyasny Asset Management L.P. · Added
Change +1.9M Date Q1 2026
Balyasny Asset Management L.P. Added· Q1 2026 +1.9M Q1 2026
Millennium Management LLC · Reduced
Change −1.5M Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −1.5M Q1 2026
Bank of America Corp · Added
Change +1.2M Date Q1 2026
Bank of America Corp Added· Q1 2026 +1.2M Q1 2026
Rtw Investments, LP · Added
Change +1.2M Date Q1 2026
Rtw Investments, LP Added· Q1 2026 +1.2M Q1 2026
Hrt Financial LP · Exited
Change −995K Δ Own −100.0% Date Q1 2026
Hrt Financial LP Exited· Q1 2026 −995K −100.0% Q1 2026
Sio Capital Management, LLC · Added
Change +930K Date Q1 2026
Sio Capital Management, LLC Added· Q1 2026 +930K Q1 2026
D. E. Shaw & Co., Inc. · Reduced
Change −923K Δ Own −98.1% Date Q1 2026
D. E. Shaw & Co., Inc. Reduced· Q1 2026 −923K −98.1% Q1 2026
Federated Hermes, Inc. · Added
Change +908K Date Q1 2026
Federated Hermes, Inc. Added· Q1 2026 +908K Q1 2026
Blue Owl Capital Holdings LP · Added
Change +823K Date Q1 2026
Blue Owl Capital Holdings LP Added· Q1 2026 +823K Q1 2026
Aberdeen Group PLC · Exited
Change −809K Δ Own −100.0% Date Q1 2026
Aberdeen Group PLC Exited· Q1 2026 −809K −100.0% Q1 2026
Two Sigma Investments, LP · Added
Change +758K Δ Own +199.0% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +758K +199.0% Q1 2026
Perceptive Advisors LLC · Exited
Change −747K Δ Own −100.0% Date Q1 2026
Perceptive Advisors LLC Exited· Q1 2026 −747K −100.0% Q1 2026
Propel Bio Management, LLC · New
Change +711K Date Q1 2026
Propel Bio Management, LLC New· Q1 2026 +711K Q1 2026
Trexquant Investment LP · Exited
Change −523K Δ Own −100.0% Date Q1 2026
Trexquant Investment LP Exited· Q1 2026 −523K −100.0% Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 192

Famous investor activity in Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics, Inc. (AQST) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Barber Daniel · Officer Sell −$82K
Price $4.00 Qty −20K Owned 611K ΔOwn −3.2% Trade date Jul 16, 2026 Filed date Jul 17, 2026
Barber Daniel Officer Sell $4.00 −20K −$82K 611K −3.2% Jul 16, 2026 Jul 17, 2026
Barber Daniel · Officer Sell −$19K
Price $4.03 Qty −5K Owned 631K ΔOwn −0.7% Trade date Jul 15, 2026 Filed date Jul 17, 2026
Barber Daniel Officer Sell $4.03 −5K −$19K 631K −0.7% Jul 15, 2026 Jul 17, 2026
Krop Julie · Director Sell −$125K
Price $5.02 Qty −25K Owned 0 ΔOwn −100.0% Trade date Jun 23, 2026 Filed date Jun 24, 2026
Krop Julie Director Sell $5.02 −25K −$125K 0 −100.0% Jun 23, 2026 Jun 24, 2026
Krop Julie · Director 2 operations 0
Price $0.71 Owned 0 Trade date Jun 23, 2026 Filed date Jun 24, 2026
Krop Julie Director 2 operations $0.71 0 0 Jun 23, 2026 Jun 24, 2026
Barber Daniel · Officer Sell −$104K
Price $4.16 Qty −25K Owned 636K Trade date Jun 15, 2026 Filed date Jun 16, 2026
Barber Daniel Officer Sell $4.16 −25K −$104K 636K Jun 15, 2026 Jun 16, 2026
Morris Timothy E. · Director Grant (A) 50K
Owned 50K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Morris Timothy E. Director Grant (A) 50K 50K Jun 10, 2026 Jun 12, 2026
Krop Julie · Director Grant (A) 50K
Owned 50K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Krop Julie Director Grant (A) 50K 50K Jun 10, 2026 Jun 12, 2026
Jenkins Abigail L. · Director Grant (A) -50K
Owned 50K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Jenkins Abigail L. Director Grant (A) -50K 50K Jun 10, 2026 Jun 12, 2026
Cochran John · Director Grant (A) 50K
Owned 50K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Cochran John Director Grant (A) 50K 50K Jun 10, 2026 Jun 12, 2026
Brown Gregory B. · Director Grant (A) 50K
Owned 50K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Brown Gregory B. Director Grant (A) 50K 50K Jun 10, 2026 Jun 12, 2026
Taglietti Marco · Director Grant (A) 50K
Owned 50K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Taglietti Marco Director Grant (A) 50K 50K Jun 10, 2026 Jun 12, 2026
Korczynski Sherry · Officer Tax withholding or exercise payment (F) -3K
Owned 238K Trade date Jun 8, 2026 Filed date Jun 9, 2026
Korczynski Sherry Officer Tax withholding or exercise payment (F) -3K 238K Jun 8, 2026 Jun 9, 2026
Zalewski Thomas A. · Officer 2 operations 175K
Owned 75K Trade date May 18, 2026 Filed date May 19, 2026
Zalewski Thomas A. Officer 2 operations 175K 75K May 18, 2026 May 19, 2026
Barber Daniel · Officer Sell −$35K
Price $4.29 Qty −8K Owned 661K Trade date May 15, 2026 Filed date May 18, 2026
Barber Daniel Officer Sell $4.29 −8K −$35K 661K May 15, 2026 May 18, 2026
Cioffi Melina · Officer Tax withholding or exercise payment (F) -$7K
Price $4.17 Qty -2K Owned 273K Trade date May 15, 2026 Filed date May 18, 2026
Cioffi Melina Officer Tax withholding or exercise payment (F) $4.17 -2K -$7K 273K May 15, 2026 May 18, 2026
15 of 52
15 of 52 Sign in to continue to older insider transactions.

Aquestive Therapeutics, Inc. (AQST) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Bratton Douglas K 10.1M
% of shares outstanding 25.2% Filing date Feb 11, 2022
Bratton Douglas K 10.1M 25.2% Feb 11, 2022
Venrock Healthcare Capital Partners Iii, L.P. 5.6M
% of shares outstanding 6.5% Filing date Apr 1, 2024
Venrock Healthcare Capital Partners Iii, L.P. 5.6M 6.5% Apr 1, 2024
Blackrock, Inc. 8.0M
% of shares outstanding 6.4% Filing date Jul 27, 2026
Blackrock, Inc. 8.0M 6.4% Jul 27, 2026
Armistice Capital, LLC 3.9M
% of shares outstanding 5.9% Filing date Feb 14, 2024
Armistice Capital, LLC 3.9M 5.9% Feb 14, 2024
Armistice Capital, LLC
% of shares outstanding 2.9% Filing date Nov 14, 2024
Armistice Capital, LLC 2.9% Nov 14, 2024
5 of 5

Aquestive Therapeutics, Inc. (AQST) ownership FAQ

Who owns AQST?

192 reporting institutions disclosed AQST position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.